Skip to main content
Clinical Trials/IRCT20200428047229N3
IRCT20200428047229N3
Recruiting
Phase 3

Investigating the effect of cupping therapy on respiratory symptoms of patients with COVID-19

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
COVID-19.
Sponsor
Shahid Beheshti University of Medical Sciences
Enrollment
72
Status
Recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients aged 18 to 60 years
  • Diagnosis confirmation by the cooperative infectious disease specialist in the project
  • Patient's consent to participate in the project
  • With inpatient clinical criteria (fever above 38° C or severe cough or shortness of breath or respiratory rate more than 24 per minute or oxygen saturation lower than 93%)
  • Positive PCR

Exclusion Criteria

  • Current incidence of coagulopathy, obesity, deep vein thrombosis, vertebral fracture or herniated disc
  • Need for current hospitalization in ICU
  • Breastfeeding
  • Hearth failure
  • Chronic renal failure
  • Receive chemotherapy
  • Receive corticosteroids
  • Immune deficiency
  • Open wound at the site of cupping

Outcomes

Primary Outcomes

Not specified

Similar Trials